Global Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market Overview
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market size was valued at USD 1.59 billion in 2022 and is projected to grow from USD 1.89 Billion in 2023 to USD 6.6 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.9% during the forecast period (2023 - 2032).
The factors positively contributing to the growth of the market are improvement in patient outcomes and offer advantages over other imaging modalities. Â Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market Trends
- Improvement in patient outcomes and advantages over other imaging modalities fuels market growth
The rising acceptance and preference for minimally invasive surgeries (MIS) are further increasing the demand for MRI robot-assisted surgeries. This is due to quicker recovery, smaller incisions, reduced scarring and pain, increased accuracy, and shorter hospital stays. These benefits have increased the demand for MRI robot-assisted surgeries, as these robots are fully based on MIS.
Moreover, it offers several advantages over other imaging modalities. The advantages, such as providing positioning and stability accuracy through position sensing and control, which means that there is no need to move the patient out of the bore for intervention and back into the bore for surgery. Furthermore, it provides a completely intuitive user interface for planning the procedure, allowing for anatomical mapping of the patient via a scanner as well as robotic alignment.
In addition, the increasing prevalence of cancer across the globe is positively contributing to the market growth. For instance, as per the World Cancer Research Fund International, there were 18.1 million cancer cases worldwide in 2020. In this, the men's ratio was higher than the women's, and breast and lung cancer were the most common. Hence, offering several benefits over other imaging modalities and increasing prevalence of cancer globally propels market growth.
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Segment Insights
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Product Insights
The Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market segmentation, based on product, includes sensors, actuators, and robots. The sensors segment held the majority share in the market in 2022. The sensors for MRI-guided interventions are imperative for position control, tracking, and monitoring interactions. The key sensing principles apply inside the MRI through position sensors and force sensors. These sensors can be used with some distance and safety limitations.
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Application Insights
The Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market segmentation, based on application, includes oncology surgery, neurological surgery, and cardiovascular surgery. The oncology surgery segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2030. The MRI-compatible surgical robot for oncology includes prostate biopsy & brachytherapy, brain biopsy & intervention, breast cancer diagnosis & intervention, and liver cancer diagnosis & intervention. It is used to target cancerous lesions with needle-based ablation procedures in order to burn and freeze malignant cells. Currently, the robot system with MRI compatibility is primarily used for prostate biopsies. Transperineal and transrectal interventions are two methods for treating prostate cancer that are well tolerated by patients.
Figure 2: Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market, by Application, 2022 & 2030 (USD Billion)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries End User Insights
Based on end user, the global magnetic resonance imaging (MRI) robot-assisted surgeries industry has been segmented into the hospitals, ambulatory surgical centers, and specialty clinics. The hospital's segment is held the largest market share in 2022, owing to the growing preference for minimally invasive surgery (MIS) in hospitals among patients, which has significant advantages over other modalities such as open surgery, and the rising prevalence of cancer. Moreover, cancer patients are well tolerated by the methods used by magnetic resonance imaging (MRI) robots. The procedure time and MRI time decrease as physicians gain experience using the MRI-assisted robot, increases efficiency in the procedure room.
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America magnetic resonance imaging (MRI) robot-assisted surgeries accounted for the largest market share in 2022, due to the high adoption of MRI-assisted robots and the growing number of procedures owing to the high rates of cancer. As per the American Cancer Society, there were approximately 1.9 million new cancer cases in 2021 in the US.
Further, the major countries will be study are: The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: MAGNETIC RESONANCE IMAGING (MRI) ROBOT-ASSISTED SURGERIES MARKET BY REGION 2022 & 2030Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe magnetic resonance imaging (MRI) robot-assisted surgeries accounted for the second-largest market share due to technology advancements, increasing healthcare expenditure, and increasing prevalence of neurological diseases and cardiovascular diseases. For instance, according to Eurostat, there were 38,900 bypass surgeries performed in Germany in 2020. Furthermore, the Germany magnetic resonance imaging (MRI) robot-assisted surgeries attributed to hold the largest market share, and the France magnetic resonance imaging (MRI) robot-assisted surgeries is projected be the fastest growing market in the Europe region.
The Asia-Pacific magnetic resonance imaging (MRI) robot-assisted surgeries market is expected to grow at a significant rate from 2023 to 2030 owing to the growing incidence of cancer and rising geriatric population in the region. Emerging economies, such as China, Japan, and India, have largest geriatric population. Moreover, China magnetic resonance imaging (MRI) robot-assisted surgeries accounted to hold the largest market share, and the India magnetic resonance imaging (MRI) robot-assisted surgeries is projected to be the fastest growing market in the Asia-Pacific region.
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the magnetic resonance imaging (MRI) robot-assisted surgeries grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the magnetic resonance imaging (MRI) robot-assisted surgeries industry must offer cost-effective products to expand and survive in an increasingly competitive and rising market environment.
AiM Medical Robotics (US) is a neurosurgical robotics company dedicated to bringing high levels of precision, automation, and efficiency to the neurosurgery world. It is working on a portable, MRI-compatible surgical robot for use in MRI suites and operating rooms. In March 2022, the company was selected as a featured innovator at the LSI (Life Science Intelligence) 2022 Medtech Investor Summit. Moreover, in March 2022, the company raised USD 3.4 million, which was led by IQ Capital (US) and Surrey Capital (US). This funding has been used to accelerate the development of its industry-first MRI-compatible robotics platform.
Key Companies in the magnetic resonance imaging (MRI) robot-assisted surgeries market includes.
- AiM Medical Robotics (US)
- IMRIS (Canada)
- Monteris Medical (Canada)
- Machnet Medical Robotics B.V (Netherlands)
- neuro42, Inc. (US)
- ACCURAY INCORPORATED (US)
- Stereotaxis Inc. (US)
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Industry Developments
- In March 2022 AiM Medical Robotics (US) raised USD 3.4 million, which was led by IQ Capital (US) and Surrey Capital (US). This funding has been used to accelerate the development of its industry-first MRI-compatible robotics platform.
- July 2021: neuro42, Inc. (US) raised USD 6.5 million in Series A financing. The fund has been used to advance the development of an MRI-assisted robot.
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market Segmentation
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Product Outlook
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Application Outlook
- Oncology Surgery
- Prostate Biopsy & Brachytherapy
- Brain Biopsy & Intervention
- Breast Cancer Diagnosis & Intervention
- Liver Cancer Diagnosis & Intervention
- Neurological Surgery
- Cardiovascular Surgery
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries End User Outlook
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2022 |
USD 1.59 billion |
Market Size 2023 |
USD 1.89 billion |
Market Size 2032 |
USD 6.6 billion |
Compound Annual Growth Rate (CAGR) |
13.9% (2023-2032) |
Base Year |
2022 |
Forecast Period |
2023-2032 |
Historical Data |
2019 to 2021 |
Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Product, Application, End User, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered |
The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
AiM Medical Robotics (US), IMRIS (Canada), Monteris Medical (Canada), Machnet Medical Robotics B.V (Netherlands), neuro42, Inc. (US), ACCURAY INCORPORATED (US), and Stereotaxis Inc. (US) |
Key Market Opportunities |
Increasing investments for the development of MRI-compatible intraoperative robotics |
Key Market Drivers |
Improvement in patient outcomes and advantages over other imaging modalities Rising incidences of cancer |
Â
Magnetic Resonance Imaging MRI Robot-Assisted Surgeries Market Highlights:
Frequently Asked Questions (FAQ) :
The Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market is anticipated to reach 6.6 billion at a CAGR of 13.9% during the forecast period of 2023-2032.
The US is expected to hold a 55-65% share of the North America market for magnetic resonance imaging (MRI) robot-assisted surgeries in 2022.
The magnetic resonance imaging (MRI) robot-assisted surgeries is expected to grow at a 13.9% CAGR during the forecast period from 2023 to 2032.
The North America region market accounted to hold the largest market share in magnetic resonance imaging (MRI) robot-assisted surgeries.
The key players include AiM Medical Robotics (US), IMRIS (Canada), Monteris Medical (Canada), Machnet Medical Robotics B.V (Netherlands), neuro42, Inc. (US), ACCURAY INCORPORATED (US), and Stereotaxis Inc. (US).
The sensors product segment lws the magnetic resonance imaging (MRI) robot-assisted surgeries.